Luvadaxistat is an investigational D-amino acid oxidase inhibitor, a class of therapeutic agents currently under study for the treatment of schizophrenia by enhancing NMDA receptor function to address… Read more
Luvadaxistat is an investigational D-amino acid oxidase inhibitor, a class of therapeutic agents currently under study for the treatment of schizophrenia by enhancing NMDA receptor function to address cognitive and negative symptoms. This category includes high-quality reference standards of Luvadaxistat, along with its related pharmacopeial and non-pharmacopeial impurities and metabolites essential for comprehensive impurity profiling. These analytical standards are critical for laboratories performing rigorous method validation and quality control procedures during the drug development lifecycle. Additionally, researchers rely on stable isotope labelled compounds within this collection to serve as internal standards for precise quantification and structural elucidation during bioanalytical studies. By providing access to these specialized materials, the catalogue supports the development of robust analytical protocols necessary to ensure the purity, safety, and efficacy of pharmaceutical products derived from this compound.